Patents by Inventor Chenghao Ying

Chenghao Ying has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124460
    Abstract: Provided are compounds of Formula (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: October 12, 2021
    Publication date: April 18, 2024
    Inventors: Weiwen Ying, Kevin P. Foley, Wei Yin, Long Ye, Mingkai Wang, Chenghao Ying, Lingjie Zhang
  • Publication number: 20240116950
    Abstract: Provided are small molecule inhibitors of the KRAS(G12D) mutant oncoprotein having the structural formula: and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: September 8, 2023
    Publication date: April 11, 2024
    Inventors: Weiwen Ying, Chenghao Ying, Kevin P. Foley, Zhiyong Wang, Wei Yin, Liang Ma, Guoqiang Wang, Jinhua Li, Yaya Wang, Yan Dai, Thomas Prince
  • Publication number: 20230391792
    Abstract: Provided are compounds of Formula: H-L-T and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: October 14, 2021
    Publication date: December 7, 2023
    Inventors: Weiwen Ying, Kevin P. Foley, Long Ye, Mingkai Wang, Chenghao Ying, Wei Yin, Lingjie Zhang
  • Publication number: 20230391772
    Abstract: Provided are compounds of Formula (I) and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: October 13, 2021
    Publication date: December 7, 2023
    Inventors: Weiwen Ying, Kevin P. Foley, Mingkai Wang, Chenghao Ying, Long Ye, Wei Yin, Lingjie Zhang
  • Publication number: 20230365595
    Abstract: Provided are small molecule inhibitors of the KRAS(G12D) mutant oncoprotein having the structural formula: R00F2C—L—R0 and pharmaceutically acceptable salts and compositions thereof, which are useful for treating cancers and related conditions.
    Type: Application
    Filed: May 12, 2023
    Publication date: November 16, 2023
    Applicant: Ranok Therapeutics (Hangzhou) Co. Ltd.
    Inventors: Weiwen Ying, Kevin P. Foley, Chenghao Ying, Zhiyong Wang, Wei Yin, Yaya Wang, Yan Dai, Thomas Prince